Aceclidine/Brimonidine
盐酸醋克利定/溴莫尼定
Report date: 2026/05/14 20:00:28
NME
Base Information
Drug NameAceclidine/Brimonidine
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[5]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsYes Aceclidine hydrochlorideBrimonidine Tartrate
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesLenz Therapeutics Inc
China Registration ClassN/A
Develop Information
Active CompaniesLenz Therapeutics IncJi Xing Pharmaceuticals LtdCorxel Pharmaceuticals (Shanghai) Co Ltd
Inactive CompaniesN/A
Active Indications +[4]
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A